Search
for
Sort by
Research 61–90 of 718
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Eczémas de contact atypiques ou sévères à l’huile essentielle de cannelle
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Adverse Cutaneous Reactions to Antipsychotics
- Adverse Cutaneous Reactions to Antidepressants
- Psychoactive drugs and skin
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Dermatological drugs, topical agents, and cosmetics
- Cutaneous sarcoidosis masquerading as papular amyloidosis revealed post--hair removal
- Skin manifestations associated with COVID-19
- Widespread and eruptive comedonal lesions with alopecia
- Skin manifestations associated with systemic diseases – Part I
- Seborrheic keratosis
- Treatment of frontal fibrosing alopecia and lichen planopilaris
- Generalized pruritus in primary sclerosing cholangitis: implications of histamine release by lysophosphatidic acid
- General Dermatology
- Lichen‐planopilaris‐like scarring pattern in a patient with alopecia and pityriasis rubra pilaris
- Anticonvulsant-Induced Cutaneous Reactions
- Index
- Adverse Cutaneous Reactions to Mood Stabilizers
- Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia
- Description of skin lesions
- Lipid levels in patients with lichen planus: a case-control study
- Multiple minute digitate hyperkeratosis
- Adverse cutaneous effects of psychotropic medications
- Lichen Planopilaris: Update on Diagnosis and Treatment